N-[6-methoxy-2-(2-morpholin-4-yl-2-oxoethyl)indazol-5-yl]-6-morpholin-4-ylpyridine-2-carboxamide
C24H28N6O5 — CID 118182681
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[6-methoxy-2-(2-morpholin-4-yl-2-oxoethyl)indazol-5-yl]-6-morpholin-4-ylpyridine-2-carboxamide
N-[6-methoxy-2-(2-morpholin-4-yl-2-oxoethyl)indazol-5-yl]-6-morpholin-4-ylpyridine-2-carboxamide (PubChem CID 118182681) has the molecular formula C24H28N6O5 and a molecular weight of 480.53 g/mol. Its IUPAC name is N-[6-methoxy-2-(2-morpholin-4-yl-2-oxoethyl)indazol-5-yl]-6-morpholin-4-ylpyridine-2-carboxamide.
Molecular Properties
| Compound Name | N-[6-methoxy-2-(2-morpholin-4-yl-2-oxoethyl)indazol-5-yl]-6-morpholin-4-ylpyridine-2-carboxamide |
|---|---|
| PubChem CID | 118182681 |
| Molecular Formula | C24H28N6O5 |
| Molecular Weight | 480.53 g/mol |
| Exact Mass | 480.21 |
| IUPAC Name | N-[6-methoxy-2-(2-morpholin-4-yl-2-oxoethyl)indazol-5-yl]-6-morpholin-4-ylpyridine-2-carboxamide |
| SMILES | COc1cc2nn(CC(=O)N3CCOCC3)cc2cc1NC(=O)c1cccc(N2CCOCC2)n1 |
| InChI | InChI=1S/C24H28N6O5/c1-33-21-14-19-17(15-30(27-19)16-23(31)29-7-11-35-12-8-29)13-20(21)26-24(32)18-3-2-4-22(25-18)28-5-9-34-10-6-28/h2-4,13-15H,5-12,16H2,1H3,(H,26,32) |
| InChIKey | AYLVCUFENDVPDV-UHFFFAOYSA-N |
| XLogP | 1.39 |
| TPSA | 111.05 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.53 |
| LogP ≤ 5 | 1.39 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118182681 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.